4//SEC Filing
Kovner Bruce 4
Accession 0000919574-18-005044
CIK 0001634432other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:56 PM ET
Size
9.1 KB
Accession
0000919574-18-005044
Insider Transaction Report
Form 4
CDK ASSOCIATES, L.L.C.
10% Owner
Transactions
- Purchase
Ordinary Shares, $0.01 par value
2018-07-30$4.66/sh+70,000$326,466→ 5,933,834 total
CAXTON CORP
10% Owner
Transactions
- Purchase
Ordinary Shares, $0.01 par value
2018-07-30$4.66/sh+70,000$326,466→ 5,933,834 total
Kovner Bruce
10% Owner
Transactions
- Purchase
Ordinary Shares, $0.01 par value
2018-07-30$4.66/sh+70,000$326,466→ 5,933,834 total
Footnotes (1)
- [F1]These shares represent (a) 5,619,678 Ordinary Shares that are owned directly by CDK Associates, LLC, which is a reporting person, and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation; and (b) 314,156 Ordinary Shares beneficially owned by employees of an affiliate of Caxton Corporation and entities affiliated with such employees and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Strongbridge Biopharma plc
CIK 0001634432
Entity typeother
Related Parties
1- filerCIK 0001325713
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 4:56 PM ET
- Size
- 9.1 KB